Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pediatr ; 222: 71-78.e6, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32586536

RESUMO

OBJECTIVE: To assess whether chorioamnionitis is associated with cerebral palsy (CP) or death at 2 years' corrected age in infants born before 32 weeks of gestation after spontaneous birth. STUDY DESIGN: EPIPAGE-2 is a national, prospective, population-based cohort study of children born preterm in France in 2011; recruitment periods varied by gestational age. This analysis includes infants born alive after preterm labor or preterm premature rupture of membranes from 240/7 to 316/7 weeks of gestation. We compared the outcomes of CP, death at 2 years' corrected age, and "CP or death at age 2" according to the presence of either clinical chorioamnionitis or histologic chorioamnionitis. All percentages were weighted by the duration of the recruitment period. RESULTS: Among 2252 infants born alive spontaneously before 32 weeks of gestation, 116 (5.2%) were exposed to clinical chorioamnionitis. Among 1470 with placental examination data available, 639 (43.5%) had histologic chorioamnionitis. In total, 346 infants died before 2 years and 1586 (83.2% of the survivors) were evaluated for CP at age 2 years. CP rates were 11.1% with and 5.0% without clinical chorioamnionitis (P = .03) and 6.1% with and 5.3% without histologic chorioamnionitis (P = .49). After adjustment for confounding factors, CP risk rose with clinical chorioamnionitis (aOR 2.13, 95% CI 1.12-4.05) but not histologic chorioamnionitis (aOR 1.21, 95% 0.75-1.93). Neither form was associated with the composite outcome "CP or death at age 2." CONCLUSIONS: Among infants very preterm born spontaneously, the risk of CP at a corrected age of 2 years was associated with exposure to clinical chorioamnionitis but not histologic chorioamnionitis.


Assuntos
Paralisia Cerebral/etiologia , Corioamnionite , Causas de Morte , Pré-Escolar , Corioamnionite/diagnóstico , Estudos de Coortes , Feminino , Ruptura Prematura de Membranas Fetais , Humanos , Recém-Nascido Prematuro , Masculino , Gravidez , Nascimento Prematuro , Estudos Prospectivos , Fatores de Tempo
2.
Environ Res ; 142: 123-34, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26133809

RESUMO

BACKGROUND: The intensive use of chlordecone (an organochlorine insecticide) in the French West Indies until 1993 resulted in a long-term soil and water contamination. Chlordecone has known hormonal properties and exposure through contaminated food during critical periods of development (gestation and early infancy) may affect growth. OBJECTIVES: We aimed to assess the impact of prenatal and postnatal exposure to chlordecone on the growth of children from the TIMOUN mother-child cohort. METHODS: Chlordecone was determined in cord plasma at birth (N=222) and in breast milk samples (at 3 months). Dietary chlordecone intake was estimated at 7 and 18 months, with food-frequency questionnaires and food-specific contamination data. Anthropometric measurements were taken at the 3-, 7- and 18-month visits and measurements reported in the infants' health records were noted. Structured Jenss-Bayley growth models were fitted to individual height and weight growth trajectories. The impact of exposure on growth curve parameters was estimated directly with adjusted mixed non-linear models. Weight, height and body mass index (BMI), and instantaneous height and weight growth velocities at specific ages were also analyzed relative to exposure. RESULTS: Chlordecone in cord blood was associated with a higher BMI in boys at 3 months, due to greater weight and lower height, and in girls at 8 and 18 months, mostly due to lower height. Postnatal exposure was associated with lower height, weight and BMI at 3, 8 and 18 months, particularly in girls. CONCLUSION: Chlordecone exposure may affect growth trajectories in children aged 0 to 18 months.


Assuntos
Desenvolvimento Infantil/efeitos dos fármacos , Clordecona/análise , Disruptores Endócrinos/análise , Efeitos Tardios da Exposição Pré-Natal/induzido quimicamente , Estatura/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Clordecona/efeitos adversos , Clordecona/sangue , Disruptores Endócrinos/efeitos adversos , Disruptores Endócrinos/sangue , Monitoramento Ambiental , Feminino , Sangue Fetal/química , Contaminação de Alimentos/análise , Guadalupe , Humanos , Lactente , Exposição Materna/efeitos adversos , Leite Humano/química , Gravidez , Efeitos Tardios da Exposição Pré-Natal/fisiopatologia , Estudos Prospectivos , Análise de Regressão , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA